http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3999052-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50420c01f3f1dff0f3205ee8f4ba0d07
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
filingDate 2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d77e63f04b304f4ed0c8f19ee9dc53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e125c0136ece21881ab0eae76e7e64b
publicationDate 2022-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3999052-A1
titleOfInvention Immuno-oncology therapy using isoflavone compounds
abstract A method for improving a response in an individual to immuno-oncology cancer therapy, such as a checkpoint inhibitor, using an isoflavone compound of formula I.
priorityDate 2019-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414059

Total number of triples: 38.